Mark Wilterding - 31 Aug 2026 Form 4 Insider Report for RxSight, Inc. (RXST)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Sep 2026, 21:35:02 UTC
Prior SEC filing
03 Mar 2026
Next SEC filing
09 Sep 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jim Schindler, as Attorney-in-Fact

Key filing fact

Mark Wilterding filed Form 4 for RxSight, Inc. (RXST) on 02 Sep 2026.

Key facts

  • This page summarizes Mark Wilterding's Form 4 filing for RxSight, Inc. (RXST).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 02 Sep 2026, 21:35.

Change

  • Previous filing in this sequence was filed on 03 Mar 2026.
  • Current net transaction value: -$54,044.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002107187 Primary reporting owner

Wilterding Mark

Relationship
Chief Financial Officer
Address
100 COLUMBIA, ALISO VIEJO
Signature
/s/ Jim Schindler, as Attorney-in-Fact
Signature date
02 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RXST transaction

Common Stock

Options Exercise

Transaction value
Shares
+20,441
Change %
+165%
Price
Shares after
32,814
Date
31 Aug 2026
Ownership
Direct
Footnotes
F1
RXST transaction

Common Stock

Sale

Transaction value
$54,044
Shares
-7,765
Change %
-24%
Price
$6.96
Shares after
25,049
Date
02 Sep 2026
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RXST transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares
-20,441
Change %
-14%
Price
$0.000000*
Shares after
122,646
Date
31 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
20,441
Exercise price
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Footnote F2

Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person.

Footnote F3

Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one eighth (1/8th) of the shares subject to the RSU award vested on February 28, 2026, and one eighth (1/8th) of the shares subject to the RSU award will vest every six months thereafter on the last day of February and the last day of August over a four-year period.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .